Expression, purification, crystallization, and preliminary X-ray crystallographic studies of the human adiponectin

Hiroaki Tanabe1, Kanna Motoyama, Mariko Ikeda

  • 1RIKEN Systems and Structural Biology Center, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, 230-0045, Japan.

Insights

Researchers purified adiponectin receptors (AdipoR1 and AdipoR2) for type 2 diabetes research. They developed a method to prevent protein aggregation, enabling structural analysis and crystallization for drug discovery.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Molecular Medicine

Background:

  • Adiponectin receptors (AdipoR1, AdipoR2) are crucial for glucose and fatty acid metabolism, impacting type 2 diabetes.
  • Understanding AdipoR structure is key to developing metabolic disease therapeutics.

Purpose of the Study:

  • To develop a robust purification strategy for functional adiponectin receptor fragments.
  • To enable structural determination of AdipoR1 and AdipoR2 for therapeutic targeting.

Main Methods:

  • Expression of N-terminally truncated human AdipoR1 and AdipoR2 mutants in insect cells.
  • Multi-step chromatography (affinity, anion-exchange, size exclusion) to purify AdipoR1Δ88 and AdipoR2Δ99.
  • Characterization using thermostability assays, lipid binding analysis, SPR, and X-ray crystallography.

Main Results:

  • Truncated mutants AdipoR1Δ88 and AdipoR2Δ99 were successfully purified to homogeneity, overcoming aggregation issues.
  • Purified proteins demonstrated structural integrity via biophysical characterization.
  • Crystallization of AdipoR1Δ88 and AdipoR2Δ99 was achieved using the lipidic mesophase method.

Conclusions:

  • A refined purification protocol effectively yields stable, homogeneous adiponectin receptor fragments.
  • The structural data obtained provides a foundation for designing novel type 2 diabetes therapies targeting adiponectin signaling.

Related Concept Videos